These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29131394)

  • 1. Shaken or Stirred? Evaluating the combination of budesonide-surfactant for survival free of bronchopulmonary dysplasia.
    Willis K; Weems M
    Acta Paediatr; 2018 Mar; 107(3):540. PubMed ID: 29131394
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns - A systematic review.
    Moraes LHA; Coelho RMD; Neves Dos Santos Beozzo GP; Yoshida RAM; de Albuquerque Diniz EM; de Carvalho WB
    J Pediatr (Rio J); 2023; 99(2):105-111. PubMed ID: 36436670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheal Budesonide/Surfactant for Preventing Bronchopulmonary Dysplasia.
    Dani C
    Am J Respir Crit Care Med; 2016 Jul; 194(1):123. PubMed ID: 27367894
    [No Abstract]   [Full Text] [Related]  

  • 4. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
    Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
    Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply: Intratracheal Budesonide/Surfactant for Preventing Bronchopulmonary Dysplasia.
    Yeh TF; Chen CM
    Am J Respir Crit Care Med; 2016 Jul; 194(1):123-4. PubMed ID: 27367893
    [No Abstract]   [Full Text] [Related]  

  • 7. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
    Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Isayama T
    JAMA; 2021 Dec; 326(24):2475-2476. PubMed ID: 34901990
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasal continuous positive airway pressure combined with surfactant and NO for treatment of respiratory distress syndrome, prevention of bronchopulmonary dysplasia, and brain protection.
    Verder H
    Chin Med J (Engl); 2010 Oct; 123(20):2958-9. PubMed ID: 21034614
    [No Abstract]   [Full Text] [Related]  

  • 11. Neonatal surfactant therapy--where do we go from here?
    Martin RJ
    J Pediatr; 1991 Apr; 118(4 Pt 1):555-6. PubMed ID: 2007929
    [No Abstract]   [Full Text] [Related]  

  • 12. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.
    Verder H; Bohlin K; Kamper J; Lindwall R; Jonsson B
    Acta Paediatr; 2009 Sep; 98(9):1400-8. PubMed ID: 19572989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Bronchopulmonary Dysplasia: Are Intratracheal Steroids with Surfactant a Magic Bullet?
    Bancalari E; Jain D; Jobe AH
    Am J Respir Crit Care Med; 2016 Jan; 193(1):12-3. PubMed ID: 26720788
    [No Abstract]   [Full Text] [Related]  

  • 15. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
    Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
    N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of neonatal surfactant deficiency.
    Robertson B
    Perspect Pediatr Pathol; 1987; 11():6-46. PubMed ID: 3110733
    [No Abstract]   [Full Text] [Related]  

  • 19. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of early inhaled budesonide on pulmonary inflammation in infants with respiratory distress syndrome.
    Inwald DP; Trivedi K; Murch SH; Costeloe K
    Eur J Pediatr; 1999 Oct; 158(10):815-6. PubMed ID: 10486083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.